JBM (Healthcare) Limited (02161.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

3.2x

Market Cap

HKD 1.54B

MomentumView details →

1D Return

+1.61%

YTD Return

−28.95%

RSI (14)

49.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

3.2x

Market Cap

HKD 1.54B

RSI (14)

49.0

MomentumView details →

1D Return

+1.61%

YTD Return

−28.95%

ProfitabilityView details →

Gross Margin

54.38%

Net Margin

24.64%

EBITDA Margin

35.94%

ROE (TTM)

36.88%

ROA (TTM)

22.60%

Asset Turnover

0.91x

GrowthView details →

Revenue YoY

+38.35%

EPS YoY

+131.79%

FCF YoY

+3.12%

Revenue CAGR 3Y

+17.06%

EPS CAGR 3Y

+57.49%

EBITDA YoY

+86.40%

EarningsView details →

EPS (Actual)

HKD 0.12

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.36x

Current Ratio

1.90x

Quick Ratio

1.59x

Div Yield

5.16%

Div Rate

HKD 0.10

Div Growth 1Y

−65.41%

Financials snapshotView financials →

Revenue (TTM)

1.62B

Net Income (TTM)

398.35M

Op. CF (TTM)

377.60M

Next earningsNov 17, 2026 →

Latest newsMore news →

JBM Healthcare (02161.HK) announced a proposed spin-off of its branded Chinese patent medicine and Chinese medicine clinic services business, including Po Chai Pills, for a separate listing on the Main Board of the Stock Exchange of Hong Kong via a global offering of Po Chai Yuan shares.47d ago

JBM (Healthcare) Limited recommended a final dividend of HK7.35 cents per share.74d ago

Similar companies

Phibro Animal Health CorporationPAHC Dawnrays Pharmaceutical (Holdings) Limited02348.HK ANI Pharmaceuticals, Inc.ANIP Harrow Health, Inc.HROW Golden Throat Holdings Group Company Limited06896.HK ST金花600080.SH Find similar companies →

Latest newsMore news →

JBM Healthcare (02161.HK) announced a proposed spin-off of its branded Chinese patent medicine and Chinese medicine clinic services business, including Po Chai Pills, for a separate listing on the Main Board of the Stock Exchange of Hong Kong via a global offering of Po Chai Yuan shares.47d ago JBM (Healthcare) Limited recommended a final dividend of HK7.35 cents per share.74d ago JBM (Healthcare) Limited announced its FY2026 annual results, reporting revenue growth of 6.7% and a 1.9% increase in profit attributable to shareholders.74d ago